#United States #New York #La Roche-Posay #bemotrizinol #Anthelios SPF 50

La Roche-Posay's New Sunscreen Breaks New Ground

In an exciting development for sun protection, La Roche-Posay announces the launch of Anthelios UV Defense SPF 50. This groundbreaking sunscreen features Bemotrizinol (BEMT), marking the first new UV filter approved by the FDA in over 25 years. This formula brings enhanced UVA protection to the U.S. market, a significant stride for dermatological skincare.

Why BEMT is a Game-Changer

Bemotrizinol is primarily utilized in European sunscreens and offers broad-spectrum coverage against UVA and UVB rays, with efficiency extending up to 370 nm. La Roche-Posay, a leader in sun protection with over 40 years of experience, expresses enthusiasm over finally bringing this advanced formula to American consumers. The introduction comes at a crucial time, as skin cancer rates continue to rise, making daily sun protection more vital than ever.

Features and Benefits of Anthelios UV Defense SPF 50

Anthelios UV Defense SPF 50 boasts a lightweight, milky texture that effortlessly integrates into the skin, leaving no white cast. Each application promises hydration for up to 24 hours, thanks to its innovative formulation. The sunscreen also comprises the proprietary Cell-Ox Shield® technology, integrated with Litchiderm and EXO-P, aimed at providing robust defense against environmental damage, pollution, and oxidative stress for up to 16 hours.

• - Litchiderm, derived from the Litchi Pericarp Chinensis extract, amplifies the formula's antioxidant defense.
• - EXO-P, which comes from Alteromonas Ferment Extract, serves as a biomimetic shield, protecting the skin from urban pollution and harmful smoke.

Expert Insights

Grace Riggenbach, General Manager of La Roche-Posay U.S., emphasizes the brand's commitment to improving dermatological health and quality of life. With shocking statistics revealing that one in five Americans will develop skin cancer in their lifetime, there is a pressing need for users to adopt a daily sunscreen routine. Despite these statistics, it is noted that only 11% of the population consistently applies sunscreen. Riggenbach asserts that the new Anthelios UV Defense aims to bridge this gap by offering a sunscreen that feels pleasant and non-intrusive enough to encourage daily use.

Steve Lynch, Associate Vice President of Skincare Development at L'Oréal Group, adds that while BEMT is a new addition to U.S. formulations, La Roche-Posay has significant experience working with it internationally. He underscores the importance of a comprehensive understanding of how BEMT interacts within the entire sunscreen system to ensure stable and effective skin protection.

Dermatologist-Tested for Sensitive Skin

Recognizing the importance of formulation safety, Anthelios UV Defense SPF 50 has undergone rigorous dermatologist testing, ensuring it is suitable for even the most sensitive skin types. The product will launch on October 20, 2026, priced at $39.99, and will be available on LaRochePosay.us and Amazon.com.

About La Roche-Posay

La Roche-Posay is globally recognized, with recommendations from 100,000 dermatologists. Their mission revolves around providing effective dermatological skincare tailored to various skin concerns. Central to this commitment is the exclusive selenium-rich La Roche-Posay Thermal Spring Water, renowned for its soothing and antioxidant properties. This launch reflects the brand’s dedication to innovation, development, and utmost care for skincare safety, with over 750 studies conducted over 25 years.